DSE:PURABIGEN

Purabi General Insurance Company Limited announcements

293 Dhaka Stock Exchange announcements for Purabi General Insurance Company Limited (PURABIGEN) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (18).

  1. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 1.15 for January-September, 2017 as against Tk. 0.93 for January-September, 2016. NOCFPS was Tk. 0.24 for January-September, 2017 as against Tk. 0.63 for January-September, 2016. NAV per share was Tk. 13.01 as on September 30, 2017 and Tk. 11.69 as on September 30, 2016.

  2. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2017 at 5:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2017.

  3. Dividend Disbursement

    The Company has informed that it has credited the Bonus shares for the year ended on December 31, 2016 to the respective shareholders' BO Accounts on August 22, 2017.

  4. Q2 Financials

    (Q2 Un-audited): EPS was Tk. 0.25 for April-June, 2017 as against Tk. 0.36 for April-June, 2016; EPS was Tk. 1.05 for January-June, 2017 as against Tk. 0.56 for January-June, 2016. NOCFPS was Tk. 0.14 for January-June, 2017 as against Tk. 0.48 for January-June, 2016. NAV per share was Tk. 14.10 as of June 30, 2017 and Tk. 12.40 as of June 30, 2016.

  5. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 29, 2017 at 5:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on June 30, 2017.

  6. Resumption after Record Date

    Trading of the shares of the Company will resume on 10.07.2017 after record date for EGM.

  7. Suspension for Record Date

    Trading of the shares of the Company will remain suspended on record date i.e., 09.07.2017 for EGM.

  8. Spot News for EGM

    Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle from 05.07.2017 to 06.07.2017. Trading of the shares of the Company will remain suspended on record date i.e., 09.07.2017 for EGM.

  9. Resumption after Record Date

    Trading of the shares of the Company will resume on 13.06.2017 after record date.

  10. Suspension for Record Date

    Trading of the shares of the Company will remain suspended on record date i.e., 12.06.2017.

  11. EGM to increase Authorized Capital of the Company

    The Company has informed that the Board of Directors has decided to increase the Authorized Capital of the Company from Tk. 50.00 crore to Tk. 100.00 crore subject to approval of the shareholders in the EGM and the Regulatory Authorities. Date of EGM: 30.07.2017, Time: 4:00 PM, Venue: MH Samorita Hospital & Medical College Auditorium, 117 Tejgaon, Love Road, Dhaka-1208. Record date for EGM: 09.07.2017.

  12. Spot News

    Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 08.06.2017 to 11.06.2017. Trading of the shares of the Company will remain suspended on record date i.e., 12.06.2017.

  13. Changing time of EGM

    The Company has further informed that 4th EGM of the Company will be held on July 30, 2017 at 2:00 PM instead of 4:00 PM. Other information of the EGM will remain unchanged.

  14. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.80 for January-March, 2017 as against Tk. 0.20 for January-March, 2016. NOCFPS was Tk. 0.03 for January-March, 2017 as against Tk. 0.40 for January-March, 2016. NAV per share was Tk. 13.83 as of March 31, 2017 and Tk. 12.02 as of March 31, 2016.

  15. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 14, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on March 31, 2017.

  16. Dividend Declaration

    The Board of Directors has recommended 10% stock dividend for the year ended on 31.12.2016. Date of AGM: 30.07.2017, Time: 3:00 PM, Venue: Aditorium of M.H. Samorita Hospital & Medical College, 117 Tejgaon, Dhaka. Record Date: 12.06.2017. The Company has also reported EPS of Tk. 1.20, NAV per share of Tk. 13.03 and NOCFPS of Tk. 0.45 for the year ended on 31.12.2016 as against Tk. 1.25 (restated), Tk. 11.83(restated) and Tk. 0.62 (restated) respectively for the same period of the previous year.

  17. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (02.05.2017) following its corporate declaration.

  18. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2017 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2016.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.